T1	Participants 389 391	We
T2	Participants 449 478	PATIENTS AND METHODS Patients
T3	Participants 1024 1036	178 patients
T4	Participants 1012 1014	we
T5	Participants 1135 1149	propofol group
T6	Participants 1246 1254	patients
T7	Participants 1365 1373	propofol
T8	Participants 1695 1703	patients
